Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 1, 2025

Conditions
Pain AssessmentQuality of Life (QOL)Analgesic Use
Interventions
DRUG

Supplemental Postoperative Bupivacaine

This is the intervention of interest. A supplemental injection of bupivacaine will be given postoperatively to patients who are assigned this intervention.

DRUG

Placebo Injection

This intervention will appear to give patients an additional injection, but no additional drug will be given.

Trial Locations (1)

10010

RECRUITING

New York University College of Dentistry, New York

All Listed Sponsors
lead

New York University

OTHER